1-3 of 3
Andrea Spadaro, MD
Close
Sort by
Journal Articles

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Giuseppe Milone, MD, Massimo Martino, Annalia Di Marco, BS, Salvatore Leotta, MD, Andrea Spadaro, MD, Mara Morelli, MD, Giuseppe Avola, Maria Grazia Camuglia, Alessandra Cupri, MD, Valentina Zammit, MD, Potito Rosario Scalzulli, MD, Calafiore Valeria, MD, Attilio Olivieri, MD, Giovanni Tripepi, PhD
Journal: Blood
Blood (2015) 126 (23): 4305.
https://doi.org/10.1182/blood.V126.23.4305.4305
Published: 2015
Journal Articles

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Giuseppe Milone, MD, Giuseppe Avola, Maria Grazia Camuglia, Salvatore Leotta, MD, Alessandra Cupri, Andrea Spadaro, MD, Giovanni Tripepi, MD
Journal: Blood
Blood (2014) 124 (21): 1160.
https://doi.org/10.1182/blood.V124.21.1160.1160
Published: 2014
Journal Articles

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

Giuseppe Milone, MD, Massimo Martino, MD, Potito R Scalzulli, M.D., Andrea Spadaro, MD, Valentina Di Martina, MD, Elena Schinocca, MD, Eleonora Spina, MD, Annalia Di Marco, BS, Alessandra Cupri, Giovanni Tripepi, MD, Salvatore Leotta, MD
Journal: Blood
Blood (2013) 122 (21): 4509.
https://doi.org/10.1182/blood.V122.21.4509.4509
Published: 2013